entity

HCAR2

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about HCAR2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

3Connections
1Hypotheses
1Analyses
2Outgoing
1Incoming
0Experiments
1Debates

No AI portrait yet

Wiki Pages (1)

Knowledge base pages for this entity

GPR109A (HCAR2) Agonists for Neurodegeneration

therapeutic · 557 words

Outgoing (2)

TargetRelationTypeStr
h-5b35f7a5targeted_byhypothesis1.00
neurodegenerationpromoted: Beta-Hydroxybutyrate Receptor (HCAR2) Signaling Links Ketone Deficiency to Neuroinflammationdisease0.65

Incoming (1)

SourceRelationTypeStr
h-5b35f7a5targetshypothesis1.00

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Beta-Hydroxybutyrate Receptor (HCAR2) Signaling Links Ketone 0.808 neurodegeneration What are the precise temporal dynamics o

Mentioning Analyses (1)

Scientific analyses that reference this entity

What are the precise temporal dynamics of astrocyte ketone production decline du

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.808

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

The debate identified a critical therapeutic window when astrocytic ketone produ

closed · Rounds: 4 · Score: 0.85 · 2026-04-15

Related Research

Hypotheses and analyses mentioning HCAR2 in their description or question text

No additional research found